From the Departments of Neurology & Program in Trauma (N.A.M.), Neurosurgery (J.M.S.), and Neurology & Stroke Program (S.C.), University of Maryland School of Medicine, Baltimore.
Neurology. 2024 Aug 27;103(4):e209714. doi: 10.1212/WNL.0000000000209714. Epub 2024 Jul 29.
The incidence of primary intracerebral hemorrhage (ICH) is increasing, particularly in younger patients, in part, because of increased prescription of anticoagulants. The ICH incidence rate from 2016 to 2018 in the United States was nearly 79 per 100,000 person-years and as high as 367 per 100,000 person-years among those 75 years or older. Worldwide, ICH comprises 28% of all new strokes, but a higher disease burden than ischemic stroke because of its higher morbidity and mortality. While mortality seems to be decreasing, functional outcomes are not improving. After negative trials of open surgical evacuation, recent trials of medical management strategies including intensive blood pressure control and prothrombotic agents intended to reduce hematoma expansion failed to demonstrate efficacy. Concomitantly, continued interest in minimally invasive surgical approaches arose from appreciation of secondary iatrogenic injury incurred to subcortical white matter tracts from open surgical techniques. A positive trial of minimally invasive surgery for lobar hemorrhage has recently been reported, bringing new optimism and demanding a reconsideration of surgical management of ICH. In this narrative review, we summarize the landmark studies, review recent literature, and consider the outstanding questions surrounding surgical management of ICH.
原发性脑出血 (ICH) 的发病率正在上升,尤其是在年轻患者中,部分原因是抗凝药物的处方增加。美国 2016 年至 2018 年的 ICH 发病率接近每 10 万人 79 例,而 75 岁及以上人群的发病率高达每 10 万人 367 例。在全球范围内,ICH 占所有新发脑卒中的 28%,但其发病率和死亡率都更高,因此疾病负担比缺血性脑卒中更重。尽管死亡率似乎在下降,但功能预后并没有改善。在开颅手术清除血肿的阴性试验之后,最近关于包括强化降压和抗血栓药物在内的旨在减少血肿扩大的药物治疗策略的试验未能显示出疗效。与此同时,人们对微创手术方法的持续关注源于对皮质下白质束因开颅手术技术而造成的继发性医源性损伤的认识。最近报告了一项微创治疗额叶出血的阳性试验,为手术治疗 ICH 带来了新的希望,并要求重新考虑 ICH 的手术治疗。在这篇叙述性综述中,我们总结了标志性研究,回顾了最近的文献,并讨论了手术治疗 ICH 方面的悬而未决的问题。